Edwards Lifesciences Corporation Stock
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.17 USD | -3.49% |
|
-7.39% | -9.48% |
| 05-04 | Edwards Lifesciences Names Theodora Mistras as CFO | MT |
| 05-04 | Edwards Lifesciences announces appointment of CFO | RE |
| Capitalization | 44.43B 37.71B 34.53B 32.56B 60.73B 4,233B 61.22B 410B 160B 2,016B 167B 163B 6,977B | P/E ratio 2026 * |
27.4x | P/E ratio 2027 * | 23.6x |
|---|---|---|---|---|---|
| Enterprise value | 40.92B 34.73B 31.8B 29.99B 55.93B 3,899B 56.38B 377B 147B 1,857B 154B 150B 6,426B | EV / Sales 2026 * |
6.07x | EV / Sales 2027 * | 5.31x |
| Free-Float |
87.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -3.49% | ||
| 1 week | -7.39% | ||
| Current month | -7.58% | ||
| 1 month | -0.90% | ||
| 3 months | -2.72% | ||
| 6 months | -9.38% | ||
| Current year | -9.48% |
| 1 week | 76.49 | 84.42 | |
| 1 month | 76.49 | 85.06 | |
| Current year | 74.66 | 87.32 | |
| 1 year | 72.3 | 87.89 | |
| 3 years | 58.93 | 96.12 | |
| 5 years | 58.93 | 131.73 | |
| 10 years | 27.04 | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2023-05-10 | |
Scott Ullem
DFI | Director of Finance/CFO | 59 | 2013-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 2019-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 2024-05-06 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 2015-02-09 |
| Director/Board Member | 58 | 2023-05-10 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.49% | -7.39% | +4.74% | -13.08% | 44.43B | ||
| -2.67% | -2.16% | +12.27% | -14.57% | 168B | ||
| -6.67% | -7.14% | -21.71% | +38.42% | 149B | ||
| -2.71% | -4.32% | -12.23% | -27.85% | 118B | ||
| -1.04% | -6.12% | -48.11% | -0.04% | 79.33B | ||
| +0.76% | -3.78% | -30.58% | -37.00% | 44.14B | ||
| -1.99% | +15.30% | +1.17% | +29.41% | 34.17B | ||
| -3.60% | -0.64% | +4.24% | -12.69% | 31.5B | ||
| -0.82% | +0.48% | -24.46% | -44.35% | 30.12B | ||
| -3.87% | -5.09% | -18.89% | -15.82% | 28.83B | ||
| Average | -1.89% | -0.86% | -13.36% | -9.76% | 72.73B | |
| Weighted average by Cap. | -1.66% | -2.70% | -11.92% | -4.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.75B 5.73B 5.24B 4.94B 9.22B 643B 9.3B 62.19B 24.27B 306B 25.32B 24.78B 1,060B | 7.41B 6.29B 5.76B 5.43B 10.13B 706B 10.21B 68.28B 26.65B 336B 27.8B 27.21B 1,163B |
| Net income | 1.64B 1.39B 1.27B 1.2B 2.24B 156B 2.25B 15.08B 5.88B 74.22B 6.14B 6.01B 257B | 1.89B 1.6B 1.47B 1.39B 2.58B 180B 2.61B 17.43B 6.8B 85.81B 7.1B 6.95B 297B |
| Net Debt | -3.51B -2.98B -2.73B -2.57B -4.8B -334B -4.84B -32.35B -12.63B -159B -13.17B -12.89B -551B | -5.13B -4.35B -3.99B -3.76B -7.01B -489B -7.07B -47.26B -18.45B -233B -19.24B -18.84B -805B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-11 | 77.17 $ | -3.49% | 5,262,032 |
| 26-05-08 | 79.96 $ | -3.38% | 4,031,273 |
| 26-05-07 | 82.76 $ | -0.53% | 3,332,532 |
| 26-05-06 | 83.20 $ | +0.35% | 5,083,742 |
| 26-05-05 | 82.91 $ | -0.50% | 3,288,318 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















